Predictive accuracy of plasma markers for Alzheimer’s disease, cerebrovascular disease, and cognition in a population‐based study

Julia Neitzel, Anna M Streiber, Yuan Ma, Phuong Thuy Nguyen Ho, Frank J. Wolters, Albert Hofman, Daniel Bos, Meike W. Vernooij · 2025

Read Predictive accuracy of plasma markers for Alzheimer’s disease, cerebrovascular disease, and cognition in a population‐based study by Julia Neitzel, Anna M Streiber, Yuan Ma, Phuong Thuy Nguyen Ho, Frank J. Wolters, Albert Hofman, Daniel Bos, Meike W. Vernooij (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11716496.txt.

Description

Julia Neitzel and seven co-authors published a study in 2025 on how well blood markers predict later brain problems in the general public. Most marker studies use clinic patients, who differ from the wider population doctors actually serve. This team worked with a long-running population study in Rotterdam.

They measured five markers in 625 dementia-free adults, then waited about seven years. Follow-up brought brain scans and thinking tests for everyone. The researchers checked how well each early marker, alone or combined, predicted amyloid build-up, white matter damage, and low test scores. Age and sex already shaped marker levels at the start. Results like these tell clinics what a blood result is worth years ahead.

Catalog record

CREATORJulia Neitzel, Anna M Streiber, Yuan Ma, Phuong Thuy Nguyen Ho, Frank J. Wolters, Albert Hofman, Daniel Bos, Meike W. Vernooij
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11716496

Browse the full library · About the Tower of Babel